Publication Name	World Journal of Gastroenterology
Manuscript ID	14610
Country	South Korea

Received	2014-10-15 08:18
Peer-Review Started	2014-10-15 10:43
To Make the First Decision	2014-11-14 19:02
Return for Revision	2014-11-18 15:03
Revised	2014-11-27 06:26
Second Decision	2015-01-10 12:27
Accepted by Journal Editor-in-Chief	2015-01-11 04:25
Accepted by Company Editor-in-Chief	2015-01-16 18:12
Articles in Press	2015-01-16 18:18
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-02-03 19:28
Typeset the Manuscript	2015-04-13 15:54
Publish the Manuscript Online	2015-04-27 16:22

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Randomized Clinical Trial
Article Title	Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease
Manuscript Source	Unsolicited Manuscript
All Author List	Jae Jin Hwang, Dong Ho Lee, Ae-Ra Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park and Nayoung Kim
Funding Agency and Grant Number
Corresponding Author	Dong Ho Lee, MD, Department of Internal Medicine, Seoul National University Bundang Hospital, No. 300 Gumi-dong, Bundang-gu, Seongnam 463-707, Gyeonggi-do, South Korea. dhljohn@yahoo.co.kr
Key Words	Helicobacter pylori; First-line eradication treatment; Moxifloxacin; Sequential therapy; Eradication rate
Core Tip	This is the first study to evaluate the efficacy of 14-d moxifloxacin-based sequential therapy compared to that of 14-d clarithromycin-based sequential therapy as a first-line eradication treatment of Helicobacter pylori infection. Our study showed that the moxifloxacin-based therapy is effective and shows excellent patient compliance and safety compared with the clarithromycin-based sequential therapy. The high eradication rate, excellent compliance, and safety of the moxifloxacin-based sequential therapy suggest its suitability as an alternative to standard triple therapy.
Publish Date	2015-04-27 16:22
Citation	Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease. World J Gastroenterol 2015; 21(16): 5032-5038
URL	http://www.wjgnet.com/1007-9327/full/v21/i16/5032.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i16.5032

Full Article (PDF)	WJG-21-5032.pdf
Full Article (Word)	WJG-21-5032.doc
Manuscript File	14610-Review.docx
Answering Reviewers	14610-Answering reviewers.pdf
Biostatistics Review Certificate	14610-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	14610-Conflict-of-interest statement.pdf
Copyright License Agreement	14610-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	14610-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	14610-Language certificate.pdf
Peer-review Report	14610-Peer-review(s).pdf
Scientific Misconduct Check	14610-CrossCheck.jpg
Scientific Editor Work List	14610-Scientific editor work list.pdf